At NTA our core business is to coordinate, support and facilitate clinical trials across investigators, sites and centres.
Whether you are a local biotechnology company, international pharmaceutical company, or Australian clinical neuroscientist, NTA is your ideal clinical development partner. NTA is the only Australian clinical neuroscience cooperative group, and plays a lead role in the facilitation of clinical trials in our region. Supporting a membership made up of the range of clinical specialty groups across the neurosciences, we provide access to key opinion leaders and clinical trial expertise through a range of tailored clinical trials services.
We are responsive to the demand for high-quality, timely, ethical and cost-effective clinical trials.
Services to Industry
NTA plays an important communications role as a professional interface between investigators and industry helping to bring better health outcomes to the community through innovation and excellence in clinical trials.
NTA provides a single point of contact for a range of clinical trial services from clinical program development, study design, protocol review, regulatory advice, study feasibility, site selection, statistical advice and data management, to monitoring and project management, either directly or via a network of strategic business alliances.
NTA provides improved efficiency across the clinical trial process via a centralised service offering.
- Single communication channel
- Simplified feasibility analyses matching site capabilities to study requirements
- Unmatched specialisation across the range of neuroscience disciplines
NTA is your ideal clinical development partner. We understand the development pathway and as the clinical trials platform of the National Neuroscience Facility, we enjoy access to the leading preclinical service providers in the country. We provide unmatched clinical neuroscience expertise via our management board of key opinion leaders representing the various specialty groups from across the clinical neurosciences. Our staff members are experienced in neuroscience as a therapeutic area and have extensive knowledge of local and international clinical and regulatory requirements.
Services to support investigator-initiated studies
Our main objective is to bring together, support and promote neuroscience clinical investigators and to facilitate interactions with the biotechnology and pharmaceutical industries both nationally and internationally. In doing so, we aim to assist in the translation of quality research into clinical practice, and ultimately better health outcomes for the general public. NTA promotes the collective capabilities of Australian neuroscience investigators to attract more and earlier phase studies to our region.
Building from an initial offering of administrative services, we aim to directly support investigator initiated research via a combination of seed funding and project related services as we build our research fund and develop our human resources. Investigators interested in discussing their project needs are invited to contact Dr Peter Keller via email: pkeller@neurotrialsaustralia.com or telephone (03) 9496 4482.